WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Perspectives on Use of Artificial Intelligence/Machine Learning (AIML) for Driving Commercial Performance.” The report, based on responses from 23 different biopharma companies, finds that 90 percent of large pharmaceutical companies initiated AIML projects in 2020 compared to 60 percent of emerging biopharma companies.
Marketing mix, patient identification and healthcare practitioner targeting were the most frequently sited use cases…
Read Now
Waltham, MA, December 16, 2020 — Trinity Life Sciences, the leader in global life sciences solutions, found that the key themes from last month’s virtual TGaS Fall Summit included COVID’s impact on engagement and the life sciences commercial model as well as how to lead the commercial model transformation in 2021.
The 350 attendees from 111 life sciences companies joined the Summit and participated in conversations about:
Team engagement and motivationThe new commercial model, including modifications in client-facing roles and…
Read Now
Waltham, MA, December 8, 2020 — Trinity Life Sciences, the leading commercial partner to the life sciences industry, announced the acquisition of New Jersey-based BluePrint Research Group. The acquisition positions Trinity as the premier partner for commercially focused strategy, insights and analytics for the life sciences industry and solidifies its global presence. BluePrint Research Group adds a London office to Trinity’s international presence as well as increases its current resources in India and the East and West Coasts of the…
Read Now
CCOs Are Finding Creative Ways to Attract and Retain Talent, According to the New TGaS Report from Trinity Life Sciences
Waltham, MA, November 19, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Building Commercial Teams in the Age of COVID.” The report, targeted at emerging biopharma chief commercial officers (CCOs), reveals trends in building teams and culture during the COVID pandemic.
The report, based on 26…
Read Now
Waltham, MA, November 5, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, announced the winners of the TGaS Best of Benchmark (BoB) Awards. The Awards, which are given for commercial operations excellence within the pharmaceutical industry, were presented to teams at Merck (known as MSD outside the United States and Canada), Gilead, Sanofi, Janssen Oncology, Genentech and Horizon Therapeutics. The BoBs are based on TGaS benchmarking of large, midsize and emerging life sciences companies.
While the…
Read Now
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life sciences solutions, introduces a new field force impact benchmarking service called Trinity Stakeholder Voice. The service offers critical insights for biopharmaceutical companies looking to lead the market in a new and changing reality.
Stakeholder Voice reveals how healthcare providers really feel about their pharmaceutical sales representatives and/or medical science liaisons. The service allows biopharma companies to benchmark how their frontline teams are doing in terms of outreach frequency and quality…
Read Now
WALTHAM, Mass.–(BUSINESS WIRE)–Trinity Life Sciences, a leader in global life science solutions, has published a comprehensive report entitled Launching During COVID-19, Assessing the Damage and Finding Success. The paper uncovers some surprising and concerning issues related to launching a drug during COVID-19, details case studies of drugs that have launched during the pandemic and provides important takeaways for life science companies now preparing for launch.
According to the white paper, it is possible to successfully launch a new product during…
Read Now
Waltham, MA, October 21, 2020 — Trinity Life Sciences, a leader in global life sciences solutions, is sharing findings from its latest TGaS Landscape report entitled, “Tenth Annual Incentive Compensation Landscape.” This detailed report is based on interviews of 38 biopharmaceutical incentive compensation (IC) leaders who shared their experience on IC planning including:
Challenges and the FuturePlan MechanicsGoal SettingContests and SPIFFs (sales performance incentive funds)President’s ClubAdjustmentsIC Governance
The benefit of publishing the report every year allows its authors to reveal…
Read Now
Waltham, MA, September 21, 2020 – Trinity Life Sciences, a leader in global life sciences solutions, introduces Trinity EvidenceFirst™, a high-value subscription service that allows biopharmaceutical companies to take advantage of real-world insights like never before. EvidenceFirst allows organizations to benefit from big, robust data without dealing with the complexities, resource requirements, and costs associated with large data sets. With EvidenceFirst, biopharmaceutical companies can now utilize real-world insights on a broader range of projects with faster turnaround times.
The combination…
Read Now
Waltham, MA, September 16, 2020 – Trinity Life Sciences, a global leader in life sciences solutions, today announced the appointment of Rebecca McNamara as Chief Financial Officer (CFO) reporting directly to Dave Fitzhenry, Trinity’s CEO.
Ms. McNamara has a proven track record for leading growth strategies as well as complex operational initiatives and capital allocation strategies. She joins Trinity from Boston-based Cengage where she most recently served as the Chief Integration Officer. Ms. McNamara will lead Trinity’s already world-class Operations…
Read Now
